Kozak & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.05K Hold
20
﹤0.01% 279
2026
Q1
$10.2K Hold
20
﹤0.01% 269
2025
Q4
$9.63K Hold
20
﹤0.01% 261
2025
Q3
$9.72K Hold
20
﹤0.01% 255
2025
Q2
$7.69K Hold
20
﹤0.01% 262
2025
Q1
$6.91K Hold
20
﹤0.01% 250
2024
Q4
$6.01K Hold
20
﹤0.01% 280
2024
Q3
$8.27K Hold
20
﹤0.01% 246
2024
Q2
$6.59K Hold
20
﹤0.01% 251
2024
Q1
$6.5K Hold
20
﹤0.01% 262
2023
Q4
$5.64K Hold
20
﹤0.01% 268
2023
Q3
$4.92K Hold
20
﹤0.01% 282
2023
Q2
$5.95K Hold
20
﹤0.01% 265
2023
Q1
$5.27K Sell
20
-58
-74% -$14.7K ﹤0.01% 266
2022
Q4
$19K Hold
78
0.01% 195
2022
Q3
$16K Buy
78
+10
+15% +$1.99K 0.01% 198
2022
Q2
$11K Buy
68
+10
+17% +$2.15K 0.01% 225
2022
Q1
$15K Hold
58
0.01% 223
2021
Q4
$15K Buy
+58
New +$14.2K 0.01% 223

Other funds holding HCA

Kozak & Associates's HCA Position: Q2 2026 in Review

Kozak & Associates held its HCA Healthcare (HCA) position steady in Q2 2026 at 20 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

Kozak & Associates first reported a position in HCA in Q4 2021 and has held it in 19 quarters since. The position peaked at $19K in Q4 2022. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Kozak & Associates held 20 shares of HCA Healthcare worth $8.05K as of Q2 2026.
  • Kozak & Associates left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #279 holding.
  • Kozak & Associates first reported a position in HCA Healthcare in Q4 2021 and has held it in 19 quarters since.
  • Kozak & Associates's HCA Healthcare position peaked at $19K in Q4 2022.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.